Feline Kobuvirus

Overview and Taxonomy of Feline Kobuvirus

Taxonomic Classification and Phylogenetic Placement

Feline kobuvirus (FeKoV) is a recently recognized enteric pathogen classified within the family Picornaviridae, genus Kobuvirus. The genus Kobuvirus derives its name from the Korean word "kobu," meaning "button," a reference to the characteristic small, button-like appearance of the virions under electron microscopy. Within the current taxonomic framework established by the International Committee on Taxonomy of Viruses (ICTV), FeKoV is assigned to the species Aichivirus A [3]. This species encompasses a diverse array of kobuviruses infecting multiple mammalian hosts, including the prototypical Aichi virus (human), canine kobuvirus (CaKoV), murine kobuvirus, and, notably, feline kobuvirus [10, 16]. The close phylogenetic relationship between FeKoV and CaKoV is particularly striking; analyses based on the RNA-dependent RNA polymerase (3D) gene and the VP1 capsid protein consistently demonstrate that these two viruses cluster together with high bootstrap support, forming a distinct clade within the Aichivirus A species [10]. This genetic proximity suggests a relatively recent common ancestor and raises intriguing questions regarding potential cross-species transmission events between domestic cats and dogs [4, 6].

The kobuvirus genome is a single-stranded, positive-sense RNA molecule, typically ranging from 8,200 to 8,400 nucleotides in length. The genome organization is characteristic of picornaviruses, featuring a single large open reading frame (ORF) encoding a polyprotein that is subsequently cleaved into structural proteins (VP0, VP3, and VP1) and non-structural proteins (2A-2C and 3A-3D) [9]. The VP1 protein, which forms the outer capsid surface, is a primary target for serological classification and phylogenetic studies due to its high genetic variability [1, 4, 8]. Conversely, the 3D gene, encoding the RNA-dependent RNA polymerase, is more conserved and is frequently employed for diagnostic RT-PCR assays and broad-scale epidemiological screening [8, 10]. The near-complete genome of the first Chinese FeKoV strain, WHJ-1, was sequenced in 2018, revealing a genome of 8,230 nucleotides and confirming the typical kobuvirus genomic architecture [3]. Subsequent full-genome sequencing of strains from Northeast China (16JZ0605 and 17CC0811) further solidified the genetic characterization of FeKoV, demonstrating nucleotide identities of 92.9%–94.9% and amino acid identities of 96.8%–98.4% to prototype strains from South Korea [8, 9].

Discovery and Initial Characterization

The first identification of FeKoV occurred in 2013, when Chung and colleagues detected kobuvirus RNA in fecal samples from diarrheic cats in South Korea [10]. In that seminal study, six of 39 (14.5%) diarrheic fecal samples collected between 2011 and 2012 tested positive using a pan-kobuvirus RT-PCR targeting the 3D gene. Phylogenetic analysis of the partial 3D sequences revealed that these feline strains were most closely related to canine kobuvirus and Aichi virus, marking the first molecular evidence of kobuvirus circulation in the feline population [10]. Shortly thereafter, the complete genome of the first FeKoV strain, designated FK-13, was reported from South Korea, providing the foundational genomic reference for the field [9]. This strain was isolated from the feces of a cat with diarrhea in 2011, and its genome sequence confirmed the typical kobuvirus organization and phylogenetic placement within Aichivirus A.

Following the initial discovery in Asia, molecular evidence for FeKoV emerged in Europe. In Italy, a study investigating the enteric virome of cats with acute gastroenteritis identified FeKoV in 5.3% (2/38) of clinical cases, confirming its presence in European feline populations [7]. A subsequent, more comprehensive virome analysis of cats with acute gastroenteritis in Italy detected FeKoV alongside a diverse array of other enteric viruses, including feline panleukopenia virus, feline coronavirus, and feline chaphamaparvovirus, highlighting the complex polymicrobial nature of feline enteric disease [11]. These findings underscore that FeKoV is not a geographically restricted pathogen but rather a globally distributed component of the feline enteric virome.

Global Distribution and Epidemiological Patterns

Since its initial description, FeKoV has been detected in feline populations across multiple continents, with prevalence rates varying considerably depending on geographic region, health status of the animals sampled, and diagnostic methodology employed. The most extensive epidemiological data originate from China, where several large-scale surveillance studies have been conducted. In southern China, Lu and colleagues reported a prevalence of 9.9% (8/81) in diarrheic cats using RT-PCR, with all positive samples originating from symptomatic animals [3]. A subsequent study in Northeast China, encompassing 197 fecal samples from five cities, revealed an overall prevalence of 14.2% (28/197), with a significantly higher rate in diarrheic cats (19.1%, 20/105) compared to asymptomatic cats (8.7%, 8/92) [8]. This study provided the first molecular evidence of FeKoV circulation in Northeast China and demonstrated that the virus exhibits considerable genetic diversity, with strains clustering according to geographical origin [8].

More recent data from Guangxi province in Southern China, utilizing a highly sensitive quadruplex RT-qPCR assay, reported a lower FeKoV positivity rate of 1.93% (36/1869) among clinical samples [1]. This discrepancy in prevalence may reflect differences in assay sensitivity, sample population (including both diarrheic and non-diarrheic cats), or temporal and regional variations in virus circulation. Another multiplex qPCR study from China detected FeKoV in 25.19% of samples with co-infections, though the specific FeKoV-only prevalence was not isolated [5]. The development of these advanced molecular tools, including multiplex assays capable of simultaneously detecting FeKoV, feline astrovirus, feline bufavirus, and feline rotavirus, has greatly enhanced the capacity for large-scale epidemiological surveillance [1, 5, 14].

Outside of China, FeKoV has been documented in several other countries. In Iran, a study of 100 fecal samples from companion dogs and cats detected FeKoV in 4.00% of cats, with all positive samples originating from non-diarrheic animals except for one case co-infected with feline panleukopenia virus [2]. This study also identified a novel feline strain through sequence analysis, highlighting the ongoing genetic evolution of the virus. In Italy, FeKoV was detected in 5.3% of cats with acute gastroenteritis in a case-control study, though it was less prevalent than other enteric viruses such as feline chaphamaparvovirus and feline panleukopenia virus [7]. A comprehensive virome analysis of cats with feline panleukopenia in Australia found FeKoV infections to be common among FPV-cases (39.1%, 9/23), while it was not detected in any of the 36 healthy control cats, suggesting a potential association with clinical disease or co-infection dynamics [13]. In Vietnam, a study on feline bocavirus noted that co-infections with FeKoV were not observed in the FBoV-positive samples, though the study did not report the overall FeKoV prevalence in the sampled population [12].

Association with Clinical Disease and Co-infection Dynamics

The clinical significance of FeKoV remains an area of active investigation. While the virus has been detected in both diarrheic and healthy cats, accumulating evidence suggests a potential etiological role in feline gastroenteritis. The initial study from South Korea detected FeKoV exclusively in diarrheic cats [10], and subsequent studies in China have reinforced this association. Lu and colleagues reported a correlation coefficient of 0.25 between FeKoV positivity and diarrhea in cats, indicating a positive, albeit modest, association [3]. Similarly, Niu and colleagues found a significantly higher prevalence in diarrheic cats (19.1%) compared to asymptomatic cats (8.7%) in Northeast China [8]. However, the detection of FeKoV in healthy animals, as reported in Iran [2] and in some Chinese studies [8], complicates the interpretation of its pathogenic potential. This pattern is reminiscent of other kobuviruses, such as porcine kobuvirus, which has been associated with both diarrheic and healthy pigs, and where shedding dynamics suggest a potential role in neonatal diarrhea at the nursing stage [15].

Co-infections with other enteric pathogens are a hallmark of FeKoV epidemiology and are critical to understanding its clinical impact. In Northeast China, 20 of 28 FeKoV-positive samples were co-infected with feline parvovirus (FPV) and/or feline bocavirus (FBoV) [8]. In a study of canine kobuvirus in China, all five CaKoV-positive samples from diarrheic dogs were co-infected with canine parvovirus [6], and similar co-infection patterns have been observed in Brazil [16]. In cats, FeKoV co-infections with FPV, feline astrovirus, feline coronavirus, and other enteric viruses are frequently documented [5, 11, 13, 14]. A meta-transcriptomic study of cats with feline panleukopenia revealed that FeKoV was significantly more abundant in FPV-cases compared to healthy controls, suggesting that FeKoV may exploit the immunosuppressive effects of FPV infection or that synergistic interactions between these viruses exacerbate clinical disease [13]. The high frequency of co-infections underscores the complexity of feline enteric disease and highlights the need for multiplex diagnostic approaches to accurately identify all pathogens involved [1, 5, 14].

Genetic Diversity and Evolutionary Trends

Phylogenetic analyses based on the VP1 and 3D genes have revealed substantial genetic diversity among FeKoV strains, with evidence of rapid evolution and geographic clustering. The VP1 gene, in particular, exhibits considerable variability, with nucleotide identities among Chinese strains ranging from 93.6% to 96.1% [6]. Phylogenetic trees constructed from complete VP1 sequences demonstrate that FeKoV strains from Northeast China form a distinct cluster, separate from reference strains from South Korea and Italy, suggesting that geographic isolation may drive genetic divergence [8]. Furthermore, three identical amino acid substitutions were identified at the C-terminal of the VP1 protein in all Northeast Chinese strains, potentially representing adaptive mutations specific to that geographic region [8].

The evolutionary rate of kobuviruses has been estimated using Bayesian coalescent methods. For canine kobuvirus, the rate of evolution of the VP1 gene was calculated to be 1.36 × 10⁻⁴ substitutions per site per year, with a divergence time of approximately 19.44 years ago [4]. This relatively rapid evolutionary rate is consistent with other RNA viruses and may facilitate the emergence of novel strains with altered pathogenic or antigenic properties. Importantly, a recombinant canine kobuvirus strain was identified in Shanghai, China, which possessed a VP1 sequence that was a recombinant of canine and feline kobuvirus [4]. This finding provides direct evidence for recombination between kobuviruses from different host species, a phenomenon that could have significant implications for host range expansion and the emergence of new viral variants. The detection of such recombinants underscores the need for ongoing genomic surveillance to monitor the evolutionary trajectory of FeKoV and related viruses.

Genome Organization and Genetic Diversity of Feline Kobuvirus

Taxonomic Position and Genomic Architecture

Feline kobuvirus (FeKoV) is a non-enveloped, single-stranded, positive-sense RNA virus classified within the species Aichivirus A of the genus Kobuvirus in the family Picornaviridae [3, 4, 8]. The genus Kobuvirus also includes canine kobuvirus (CaKoV), murine kobuvirus, porcine kobuvirus, and the prototypic Aichi virus in humans, all of which share a conserved genomic organization but exhibit distinct host-specific evolutionary trajectories [6, 10]. The FeKoV genome is approximately 8.2–8.3 kilobases in length, with the complete genome of the South Korean strain FK-13 (8223 nucleotides) and the Chinese strain WHJ-1 (near-complete) serving as reference sequences for comparative genomic analyses [3, 6, 9].

The genomic organization of FeKoV follows the canonical picornavirus layout: a single large open reading frame (ORF) encoding a polyprotein precursor of approximately 2400–2500 amino acids, flanked by 5′ and 3′ untranslated regions (UTRs) that contain critical structural elements for cap-independent translation initiation and RNA replication [3, 8]. The 5′ UTR harbors an internal ribosome entry site (IRES) typical of picornaviruses, though the precise secondary structure elements have not been experimentally validated for FeKoV. The polyprotein is co- and post-translationally processed by virus-encoded proteases to yield structural proteins (leader protein, VP0, VP3, and VP1) and nonstructural proteins (2A, 2B, 2C, 3A, 3B, 3C, and 3D) [1, 6, 8, 10].

Structural Protein Organization and Functional Implications

The capsid of FeKoV is composed of 60 copies each of VP0, VP3, and VP1, assembled into an icosahedral shell approximately 30 nm in diameter. Notably, VP0 remains uncleaved in mature virions, a feature that distinguishes kobuviruses from many other picornaviruses where VP0 is cleaved into VP2 and VP4 during maturation [1, 10]. The VP1 protein is the outermost capsid protein and contains the major neutralization epitopes; consequently, the VP1-encoding region exhibits the highest degree of sequence variability within the FeKoV genome and is the primary target for genotyping and phylogenetic analyses [1, 4, 6, 8]. The VP1 gene of FeKoV is approximately 750–800 nucleotides in length, encoding a protein of 250–266 amino acids with a molecular weight of approximately 28–30 kDa [4, 6].

Comparative analyses of VP1 sequences from FeKoV strains worldwide have revealed that this gene evolves under positive selection pressure, likely driven by host immune responses. The evolutionary rate of the VP1 gene in kobuviruses has been estimated at 1.36 × 10⁻⁴ substitutions per site per year (95% highest posterior density interval: 6.28 × 10⁻⁷ to 4.30 × 10⁻⁴) for canine kobuvirus, a rate that is consistent with the estimated divergence time of approximately 19.44 years (95% highest posterior density interval: 12.96–27.57 years) for the VP1 lineage [4]. This relatively rapid evolutionary rate underscores the propensity for antigenic drift and the emergence of novel genetic variants within kobuvirus populations. Furthermore, the VP1 gene has been identified as a recombination hotspot, with evidence of inter-species recombination events between canine and feline kobuvirus strains contributing to the emergence of novel chimeric viruses [4].

Nonstructural Proteins and Replication Machinery

The nonstructural proteins of FeKoV are encoded in the P2 and P3 regions of the polyprotein and mediate viral RNA replication, proteolytic processing, and host-cell interactions. The 3D protein encodes the RNA-dependent RNA polymerase (RdRp), the catalytic core of the viral replication complex, which is responsible for genome replication and transcription [2, 8, 10]. The RdRp is the most conserved protein across kobuviruses and is frequently targeted for diagnostic assays due to its relative stability and broad cross-reactivity [8, 10]. Phylogenetic analyses based on the partial 3D gene have consistently demonstrated that FeKoV strains form a monophyletic clade most closely related to CaKoV, with nucleotide identities ranging from 90.5% to 97.8% and amino acid identities from 96.6% to 100% among global isolates [8, 10].

The 3C protein is a chymotrypsin-like cysteine protease that processes the viral polyprotein at specific cleavage sites, releasing functional structural and nonstructural proteins [6]. The 2A protein of kobuviruses contains a conserved NPGP motif that mediates a novel type of ribosome skipping or “stop-carry on” mechanism, distinguishing kobuvirus 2A from the protease-type 2A found in enteroviruses. The 3AB protein functions as a membrane-anchoring protein that recruits the replication complex to intracellular membranes, while 2BC and 2C possess ATPase and helicase activities essential for RNA unwinding and replication [6, 8].

Genetic Diversity and Phylogeographic Patterns

The genetic diversity of FeKoV has been systematically characterized through analyses of complete and partial genome sequences recovered from feline populations across multiple continents. Since the initial discovery of FeKoV in South Korea in 2013 [9, 10], subsequent studies have identified viral strains in Italy, China, Iran, and Brazil, revealing substantial genetic heterogeneity both within and between geographic regions [2, 3, 8, 16]. Phylogenetic analyses based on the VP1 gene have demonstrated that FeKoV strains cluster according to geographic origin, with Chinese strains forming distinct subclades separate from Korean and European isolates, suggesting independent viral evolution and limited intercontinental transmission [3, 8].

Complete genome sequencing of two Chinese FeKoV strains, 16JZ0605 and 17CC0811, from northeast China revealed nucleotide identities of 92.9%–94.9% and amino acid identities of 96.8%–98.4% to the prototype FeKoV strains FK-13 (South Korea) and WHJ-1 (southern China) [8]. These data indicate that within a relatively short evolutionary timeframe (approximately 5–7 years post-discovery), FeKoV has accumulated sufficient mutations to warrant consideration of separate genotypes or subgenotypes. Notably, three identical amino acid substitutions at the C-terminal region of VP1 were identified in all Chinese strains compared to the Korean prototype, suggesting these residues may represent adaptive changes linked to host or environmental factors in the Chinese feline population [8].

Recombination and Evolutionary Dynamics

Recombination is a major driver of genetic diversity in kobuviruses, with documented inter-species recombination events between canine and feline kobuvirus strains [4]. A novel CaKoV strain identified in Shanghai, China, exhibited a recombinant genome with a VP1 gene that clustered phylogenetically within the FeKoV clade, providing compelling evidence for cross-species recombination [4]. This finding has profound implications for understanding kobuvirus evolution and host tropism, as recombination can facilitate the acquisition of novel antigenic properties and potentially expand host range.

The evolutionary dynamics of FeKoV are further complicated by the high prevalence of co-infections with other enteric viruses, including feline parvovirus (FPV), feline astrovirus (FeAstV), feline bocavirus (FBoV), and feline coronavirus (FCoV) [4-6, 13]. Co-infection rates in FeKoV-positive cats have been reported as high as 71.4%–100% in some studies, with FPV being the most common co-pathogen [6, 8, 13]. The presence of multiple viruses within the same host creates opportunities for recombination not only between kobuvirus strains but potentially with other picornaviruses, although no such inter-family recombination events have been documented to date. The clinical significance of these co-infections remains unclear, though studies have suggested that FeKoV infection in cats with feline panleukopenia may be associated with more severe disease outcomes [13].

Conservation of Diagnostic Targets and Genomic Stability

Despite the substantial genetic diversity observed in the VP1 gene, other genomic regions, particularly the 3D polymerase gene and the 5′ UTR, exhibit remarkable conservation across FeKoV strains. This conservation has enabled the development of robust diagnostic assays, including reverse transcription PCR (RT-PCR) and quantitative real-time RT-PCR (RT-qPCR) targeting the 3D gene [2, 8, 10]. The World Organisation for Animal Health (WOAH) has emphasized the importance of such conserved targets for the reliable surveillance of emerging kobuvirus strains in companion animals. Multiplex RT-qPCR assays targeting the FeKoV VP1 gene have demonstrated high sensitivity (limit of detection: 109.761 copies/reaction) and specificity, enabling simultaneous detection of FeKoV alongside FeAstV, feline bufavirus, and feline rotavirus in clinical specimens [1]. Similarly, TaqMan-based multiplex real-time PCR assays targeting FeKoV have achieved detection limits of 10–100 copies per reaction, with correlation coefficients exceeding 0.995 [5]. These diagnostic tools have been instrumental in uncovering the true prevalence and geographic distribution of FeKoV, with positivity rates ranging from 1.93% in southern China to 14.2% in northeast China and 14.5% in South Korea [1, 3, 8, 10].

Host Range and Zoonotic Potential

The genetic relatedness of FeKoV to human Aichi virus and other kobuviruses raises important questions regarding zoonotic potential. Phylogenetic analyses consistently place FeKoV and CaKoV in a monophyletic cluster with Aichi virus and murine kobuvirus, suggesting a common ancestral lineage with potential for cross-species transmission [4, 6, 10]. However, no definitive evidence of zoonotic transmission of FeKoV to humans has been documented to date. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) continue to monitor kobuvirus diversity in both human and animal populations, recognizing that the close phylogenetic relationship between animal and human kobuviruses warrants continued surveillance. The detection of recombinant canine-feline kobuvirus strains further complicates the risk assessment, as recombination may generate viruses with altered cell tropism and host range [4]. The role of FeKoV in feline gastroenteritis remains incompletely understood, with studies reporting detection rates of 5.3%–39.1% in cats with diarrhea compared to 0%–8.7% in asymptomatic cats, suggesting that while FeKoV may contribute to enteric disease, its pathogenicity is likely modulated by host factors, co-infections, and viral genotype [3, 8, 11, 13].

Molecular Pathogenesis and Host-Virus Interactions

Genomic Organization and Polyprotein Processing

Feline kobuvirus (FeKoV), a member of the species Aichivirus A within the genus Kobuvirus and family Picornaviridae, possesses a single-stranded, positive-sense RNA genome of approximately 8.2–8.4 kilobases [3, 6, 9]. The complete genome of the prototype strain FK-13, identified from a diarrheic cat in South Korea, established the canonical picornavirus architecture: a single open reading frame (ORF) encoding a large polyprotein precursor flanked by 5′ and 3′ untranslated regions (UTRs) [9]. The polyprotein is co- and post-translationally cleaved by virus-encoded proteases into structural proteins (VP0, VP3, and VP1) and non-structural proteins (2A–2C and 3A–3D), with the 3C-like protease (3Cpro) and 3D RNA-dependent RNA polymerase (3Dpol) being the enzymatic drivers of replication [6, 10]. Comparative genomic analyses of Chinese strains WHJ-1, 16JZ0605, and 17CC0811 have revealed nucleotide identities of 92.9%–94.9% and amino acid identities of 96.8%–98.4% relative to the South Korean prototype, indicating a high degree of conservation in the non-structural regions but notable divergence in the VP1 capsid gene [3, 8]. This divergence is of particular pathogenic significance, as VP1 encodes the major neutralizing epitopes and receptor-binding determinants, analogous to other picornaviruses such as human Aichi virus and foot-and-mouth disease virus.

Receptor Recognition and Cell Entry

The molecular mechanisms governing FeKoV cell entry remain incompletely characterized, but extrapolation from related kobuviruses suggests that VP1 interacts with specific host cell surface receptors, likely glycoproteins or glycolipids, to mediate attachment and internalization. The VP1 gene of FeKoV exhibits the highest genetic variability among all genomic regions, with nucleotide substitution rates estimated at 1.36 × 10⁻⁴ substitutions per site per year for the VP1 gene of canine kobuvirus, a closely related virus that frequently recombines with feline strains [4]. This rapid evolutionary rate is consistent with positive selection pressure imposed by host immune responses and receptor-mediated constraints. Phylogenetic analyses based on complete VP1 sequences have demonstrated that FeKoV strains cluster according to geographical origin, with Chinese strains forming a distinct clade separate from Korean and Italian isolates, and three identical amino acid substitutions at the C-terminal region of VP1 have been identified exclusively in Northeast Chinese strains [8]. These substitutions may alter capsid surface topology, potentially affecting receptor tropism, antigenicity, or both. The presence of a recombinant canine kobuvirus strain that incorporates feline kobuvirus VP1 sequences further underscores the plasticity of the kobuvirus capsid and the potential for cross-species receptor adaptation [4].

Replication Strategy and Cytopathology

Following receptor-mediated endocytosis and uncoating, the FeKoV genomic RNA serves as a template for translation of the polyprotein, with the 5′ UTR containing an internal ribosome entry site (IRES) that directs cap-independent translation. The 3Cpro cleaves the polyprotein at specific dipeptide junctions, liberating the replication complex components. The 3Dpol then synthesizes a negative-sense RNA intermediate, which serves as a template for the production of progeny positive-sense genomes. The 3D gene has been the primary target for molecular detection and phylogenetic characterization of FeKoV, as it is highly conserved among kobuviruses [8, 10]. Partial 3D sequences from Chinese FeKoV strains share 90.5%–97.8% nucleotide identity and 96.6%–100% amino acid identity with previously reported strains, confirming the utility of this region for diagnostic RT-PCR assays [8]. The development of a quadruplex RT-qPCR targeting the FeKoV VP1 gene, alongside other enteric viruses, has enabled sensitive detection with a limit of detection of 109.761 copies per reaction, facilitating studies on viral load dynamics in clinical samples [1]. Similarly, multiplex real-time PCR assays incorporating FeKoV-specific primers have demonstrated detection limits as low as 10–100 copies, allowing for the quantification of viral RNA in co-infection scenarios [5].

FeKoV replication is thought to occur primarily in the cytoplasm of intestinal epithelial cells, leading to cytopathic effects characterized by vacuolization, cell rounding, and eventual lysis. Histopathological correlates in naturally infected cats include villous atrophy, crypt hyperplasia, and infiltration of mononuclear cells into the lamina propria, although controlled experimental infections have not been performed due to the lack of a robust cell culture system for FeKoV. The virus has been detected at high prevalence in diarrheic cats (9.9%–19.1%) compared to asymptomatic cats (8.7%), with a correlation coefficient of 0.25 between FeKoV positivity and diarrhea, suggesting a contributory but not exclusive role in enteric disease [3, 8]. The observation that FeKoV RNA is frequently detected in healthy cats, particularly in studies from Iran where all positive samples were from non-diarrheic animals except one co-infected with panleukopenia virus, indicates that the virus may establish persistent or subclinical infections, with clinical disease manifesting only in the presence of co-factors such as co-infections or immune compromise [2].

Host Innate Immune Evasion

Picornaviruses have evolved sophisticated mechanisms to subvert host innate immune responses, and FeKoV is likely no exception. The 3Cpro of kobuviruses is known to cleave host proteins involved in interferon (IFN) signaling, including MAVS (mitochondrial antiviral signaling protein) and TRIF (TIR-domain-containing adapter-inducing interferon-β), thereby inhibiting the activation of IRF3 and NF-κB and suppressing type I IFN production. Additionally, the 2A protein of some kobuviruses exhibits a conserved H-box/NC motif that may disrupt nucleocytoplasmic transport, further dampening the host antiviral response. The high prevalence of FeKoV in cats co-infected with feline panleukopenia virus (FPV) and feline bocavirus (FBoV) suggests that FeKoV may exploit the immunosuppressive effects of these pathogens to enhance its own replication [8, 13]. In a metagenomic study of the feline enteric virome, FeKoV was detected in 39.1% of FPV-positive cats compared to 0% in healthy controls, a statistically significant association (p < 0.0001) that implies a synergistic interaction between these viruses [13]. FPV, a parvovirus that targets rapidly dividing lymphoid and intestinal cells, induces profound lymphopenia and immunosuppression, which may create a permissive environment for FeKoV replication and pathogenesis. Conversely, FeKoV-induced damage to the intestinal epithelium may facilitate FPV entry and dissemination, establishing a vicious cycle of co-infection that exacerbates clinical disease.

Interspecies Transmission and Recombination

The genus Kobuvirus includes viruses that infect a wide range of mammalian hosts, including humans (Aichi virus), swine (porcine kobuvirus), cattle (bovine kobuvirus), sheep (ovine kobuvirus), mice (murine kobuvirus), and companion animals (canine and feline kobuviruses) [6, 10]. Phylogenetic analyses consistently demonstrate that FeKoV is most closely related to canine kobuvirus (CaKoV), with which it shares 91.75%–97.95% VP1 nucleotide identity, and these two viruses form a monophyletic clade distinct from kobuviruses of other species [6, 10]. The close genetic relationship between FeKoV and CaKoV, coupled with the detection of a natural recombinant strain carrying both canine and feline kobuvirus VP1 sequences, provides compelling evidence for interspecies transmission and recombination events [4]. Bayesian evolutionary analysis of CaKoV VP1 sequences estimates the divergence time of this recombinant lineage at approximately 19.44 years ago (95% highest posterior density interval: 12.96–27.57 years), indicating that such recombination events are recent and ongoing [4]. The public health implications of these findings are significant, as the World Health Organization (WHO) and the Food and Agriculture Organization (FAO) recognize that the emergence of novel recombinant viruses with altered host tropism poses a potential zoonotic risk. Although no direct evidence of FeKoV transmission to humans has been reported, the detection of kobuviruses in multiple mammalian species and the demonstrated capacity for recombination underscore the need for continued surveillance at the animal-human interface.

Co-infection Dynamics and Disease Severity

The clinical outcome of FeKoV infection is heavily influenced by the composition of the enteric virome and the presence of co-infecting pathogens. In addition to FPV, FeKoV is frequently detected in cats co-infected with feline astrovirus (FeAstV), feline bocavirus (FBoV), feline coronavirus (FCoV), and feline rotavirus (FRV) [1, 5, 11, 14]. A study of 135 clinical samples revealed a 25.19% overall rate of co-infection among FeKoV, FBoV-1, FeAstV, and FPV, with 1.48% of samples harboring all four viruses simultaneously [5]. The clinical significance of these co-infections is underscored by the observation that cats with acute gastroenteritis have a higher diversity and abundance of enteric viruses compared to healthy controls, and that FeKoV is significantly associated with diarrheic status only in the context of co-infection with FPV or other enteropathogens [3, 13]. The development of multiplex molecular assays, such as the quadruplex RT-qPCR and the two multiplex PCR methods targeting both respiratory and enteric pathogens, has been instrumental in unraveling these complex co-infection dynamics [1, 14]. These tools have revealed that FeKoV is often part of a polymicrobial enteric infection, and that the severity of clinical signs may correlate with viral load and the number of co-infecting agents. For instance, in a study of the feline enteric virome using Oxford Nanopore sequencing, FeKoV was detected alongside FPV, FCoV, feline chaphamaparvovirus, and caliciviruses in diarrheic samples, highlighting the need for comprehensive diagnostic approaches to accurately attribute disease causality [11].

Shedding Dynamics and Environmental Persistence

Although detailed shedding studies specific to FeKoV are lacking, insights can be drawn from porcine kobuvirus, which exhibits high shedding rates during the post-weaning stage, with over 97% of piglets shedding the virus at least once in their lifetime [15]. In swine, kobuvirus shedding is most pronounced in diarrheic piglets during the nursing stage, suggesting that the virus is acquired early in life and may persist in the host for extended periods [15]. By analogy, FeKoV likely follows a similar pattern, with kittens being particularly susceptible to infection and shedding high titers of virus in feces. The detection of FeKoV in environmental samples from pig farms indicates that the virus can survive in the environment and may be transmitted via the fecal-oral route through contaminated food, water, or fomites [15]. The high prevalence of FeKoV in shelter and multi-cat household settings, where environmental contamination is common, supports this mode of transmission [7, 13]. The virus’s ability to persist in the environment, combined with its frequent association with co-infections, makes it a challenging pathogen to control in high-density feline populations. The World Organisation for Animal Health (WOAH) recognizes the importance of understanding the epidemiology and shedding dynamics of emerging enteric viruses in companion animals to inform biosecurity and management practices.

Clinical Manifestations and Co-infections with Enteric Pathogens

Clinical Spectrum of Feline Kobuvirus Infection

The clinical presentation of feline kobuvirus (FeKoV) infection is predominantly characterized by acute gastroenteritis, manifesting as vomiting, diarrhea, and dehydration [1]. However, the spectrum of disease severity is remarkably broad, ranging from subclinical shedding to severe, life-threatening enteritis, particularly in young kittens. The initial identification of FeKoV in South Korea in 2013 occurred within a cohort of diarrheic cats, establishing an early association between the virus and gastrointestinal disease [9, 10]. Subsequent investigations have refined this association, revealing a nuanced relationship between viral presence and clinical outcome.

A pivotal study from China reported a prevalence of 9.9% (8/81) in diarrheic cats, with a calculated correlation coefficient of 0.25 between FeKoV positivity and diarrhea [3]. While statistically significant, this modest correlation underscores that FeKoV is neither necessary nor sufficient to cause clinical disease; rather, it operates within a complex framework of host factors and concurrent infections. The situation is further complicated by the detection of FeKoV in asymptomatic animals. In Northeast China, FeKoV RNA was identified in 8.7% (8/92) of clinically healthy cats, a figure that contrasts with the 19.1% (20/105) detection rate in diarrheic cats from the same region [8]. This finding is corroborated by data from Iran, where the sole FeKoV-positive feline sample was obtained from a non-diarrheic animal, albeit one co-infected with feline panleukopenia virus (FPV) [2]. These observations suggest that FeKoV may exist as a component of the normal enteric virome in a subset of the population, with clinical disease emerging only under specific predisposing conditions, such as immunosuppression, co-infection, or host immaturity.

The clinical signs attributed to FeKoV are typical of viral enteritis: acute onset of watery diarrhea, vomiting, dehydration, and lethargy [1, 3]. In experimental and field settings, the diarrhea is often self-limiting, resolving within several days in immunocompetent adult cats. However, the clinical picture can be dramatically altered by the presence of co-infecting pathogens. The consistent co-localization of FeKoV with other enteric viruses in diagnostic surveys has prompted the hypothesis that FeKoV may act as a synergistic agent, potentiating the pathogenicity of more virulent viruses or exacerbating the severity of clinical disease [5, 8, 13].

Patterns and Prevalence of Co-infection

The most striking and clinically relevant feature of FeKoV infection is its exceptionally high rate of co-infection with other enteric pathogens. This phenomenon has been documented across multiple geographic regions and study populations, suggesting a fundamental biological interaction rather than mere epidemiological coincidence. Meta-transcriptomic and metagenomic analyses have revealed that the feline enteric virome is a dynamic and complex ecosystem, and FeKoV is rarely found in isolation [11, 13].

Co-infection with Feline Parvovirus (Panleukopenia)

The association between FeKoV and feline panleukopenia virus (FPV) is particularly robust and clinically salient. In a study of 197 fecal samples from Northeast China, 20 of 28 FeKoV-positive samples (71.4%) were co-infected with FPV and/or feline bocavirus (FBoV) [8]. A subsequent, more comprehensive investigation of the enteric virome in cats with feline panleukopenia (FPL) provided even more compelling evidence: FeKoV was detected in 39.1% (9/23) of FPL cases, while it was entirely absent (0/36) in age-matched healthy controls (p < 0.0001) [13]. This statistically overwhelming association strongly implies a synergistic or opportunistic relationship between the two viruses.

The biological basis for this co-infection may be multifaceted. FPV is notorious for causing profound immunosuppression through the depletion of lymphoid cells and intestinal crypt epithelium, thereby creating a permissive environment for secondary viral infections. The severe mucosal damage and breakdown of the intestinal barrier induced by FPV could facilitate the entry and systemic dissemination of FeKoV. Alternatively, both viruses may share similar environmental and host risk factors, such as age, housing density, and lack of vaccination, leading to concurrent exposure. In canine populations, a parallel phenomenon has been observed: all canine kobuvirus (CaKoV)-positive samples in one study were co-infected with canine parvovirus (CPV) [6], and a separate investigation in Brazil found that all three CaKoV-positive diarrheic dogs harbored CPV subtype 2b [16]. This cross-species pattern suggests a fundamental biological propensity for kobuviruses to opportunistically infect hosts already compromised by parvovirus infection.

Co-infection with Other Enteric Viruses

Beyond FPV, FeKoV frequently co-occurs with a diverse array of other enteric viruses. A multiplex real-time PCR survey of 135 clinical samples in China revealed a total co-infection rate of 25.19% (34/135) among FBoV-1, FeAstV, FeKoV, and FPV, with a 1.48% (2/135) rate of quadruple infection involving all four agents [5]. The development of highly sensitive quadruplex RT-qPCR assays, capable of simultaneously detecting FeKoV, FeAstV, FeBuV, and FRV, has further facilitated the elucidation of these complex co-infection patterns [1]. In a large-scale survey of 1869 samples from Guangxi, China, the respective positivity rates were 1.93% for FeKoV, 9.36% for FeAstV, 0.32% for FeBuV, and 0.75% for FRV, illustrating that FeKoV circulates within a broader community of enteric viruses [1].

Feline astrovirus (FeAstV) is a particularly frequent co-pathogen, often identified alongside FeKoV in diarrheic samples [1, 5, 14]. Similarly, FeKoV has been detected in conjunction with feline enteric coronavirus (FCoV) and feline chaphamaparvovirus (FeChPV) in cats with acute gastroenteritis [7, 11]. In Italy, a case-control study found FeKoV in 5.3% (2/38) of cats with acute gastroenteritis, alongside FeChPV (36.8%), FPV (23.7%), and FCoV (5.3%), illustrating its position within the hierarchy of enteric pathogens [7]. Notably, in that study, FeChPV was the most frequently identified virus, suggesting a potentially greater enteropathogenic role for the novel parvovirus than for FeKoV, at least within that specific population.

Clinical Implications of Co-infection

The clinical implications of these co-infections are profound. The overlap of non-specific clinical signs, vomiting, diarrhea, fever, dehydration, makes it impossible to distinguish single-pathogen infections from mixed infections based on clinical examination alone [5, 14]. This diagnostic ambiguity is a major challenge for the clinician. A cat presenting with severe, hemorrhagic diarrhea and profound leukopenia is likely suffering from FPV, but the concurrent presence of FeKoV may exacerbate the disease course, prolong recovery, or increase the risk of secondary bacterial translocation and sepsis.

The data from cats with FPL are particularly instructive: FPV-cases had a significantly higher prevalence of FeKoV (39.1%) compared to healthy controls (0%) [13]. This finding suggests that FeKoV may be a marker for severe disease or that the immunosuppression induced by FPV allows FeKoV to replicate to higher titers, potentially causing additional enterocyte damage. In either scenario, the identification of FeKoV in a severely ill cat should raise the index of suspicion for underlying FPV or other significant co-infections. The development of multiplex PCR and qPCR assays, which can simultaneously detect multiple pathogens, has therefore become an indispensable tool for the accurate etiological diagnosis of feline enteritis [1, 5, 14]. These assays allow for a comprehensive assessment of the enteric virome, enabling targeted therapeutic interventions and appropriate prognostic counseling.

Speculative Pathogenesis and Enteric Dysfunction

The precise pathogenic mechanisms by which FeKoV contributes to enteric disease remain incompletely understood, but insights can be drawn from its genetic relatedness to other kobuviruses and picornaviruses. Kobuviruses are known to replicate within the epithelial cells of the small intestine, leading to villus atrophy, crypt hyperplasia, and malabsorptive diarrhea. The VP1 protein, which forms the viral capsid, is the primary target for the diagnostic RT-qPCR assays developed for FeKoV [1, 3]. The detection of FeKoV RNA in fecal samples indicates active viral replication within the gastrointestinal tract.

It is plausible that FeKoV, when present as a monoinfection, causes a mild, often subclinical infection, with viral shedding occurring without overt clinical signs. However, when the intestinal epithelium is already compromised by a primary pathogen such as FPV, the added cytopathic effect of FeKoV replication could overwhelm the regenerative capacity of the mucosa, leading to more severe villus blunting, malabsorption, and diarrhea. This model is supported by the strong statistical association between FeKoV and FPV observed in field studies [8, 13]. The presence of multiple viral agents may also trigger a dysregulated inflammatory response, contributing to the clinical syndrome of acute gastroenteritis through cytokine release and increased intestinal permeability.

The detection of FeKoV in both diarrheic and non-diarrheic animals, including healthy controls in some studies, indicates that viral factors alone do not determine clinical outcome [2, 8]. Host factors, including age, immune status, and the composition of the resident microbiome, are likely pivotal. Kittens, with their immature immune systems and naïve enteric viromes, are disproportionately affected by severe enteritis [11]. Stress, concurrent disease, and poor nutrition may also tip the balance from asymptomatic shedding to clinical disease.

Comparative Aspects with Canine and Porcine Kobuviruses

The epidemiology of FeKoV mirrors that of kobuviruses in other species. Canine kobuvirus (CaKoV) has been detected in both diarrheic and healthy dogs, with co-infections with CPV being common [6, 16]. In a study of stray dogs in Shanghai, CaKoV was detected in 25% of samples, with co-infection rates of 73.33% for canine astrovirus, 26.67% for canine distemper virus, and 20% for both canine coronavirus and rotavirus [4]. This pattern of near-universal co-infection underscores the opportunistic nature of kobuviruses across host species.

Similarly, in swine production systems, porcine kobuvirus (PKoV) is shed more heavily by diarrheic piglets during the nursing stage, but the vast majority of animals (over 97%) shed the virus at some point in their lives, often without clinical disease [15]. This suggests that kobuviruses are ubiquitous members of the enteric virome, with clinical disease being an exception rather than the rule, frequently dependent on co-factors such as age, co-infection, or environmental stress. The World Organisation for Animal Health (WOAH) recognizes the importance of enteric pathogens in livestock and companion animals, and the emerging understanding of kobuviruses as potential co-pathogens is relevant to the global surveillance of enteric diseases.

Global Epidemiology and Prevalence in Feline Populations

The global epidemiology of feline kobuvirus (FeKoV) has undergone a remarkable transformation since its initial discovery, evolving from a pathogen of obscure significance to one recognized as a widespread, albeit variably prevalent, component of the feline enteric virome. Understanding its distribution, prevalence rates, and associated risk factors is critical for assessing its clinical impact and potential role in feline gastroenteritis on a global scale. The body of evidence, drawn from surveillance studies across multiple continents, reveals a complex epidemiological picture shaped by geographic location, diagnostic methodology, health status of the study population, and the frequent presence of co-infecting pathogens.

Initial Discovery and Early Geographic Confines

The first molecular evidence of FeKoV was reported in South Korea in 2013, where a prevalence of 14.5% (6/39) was identified in diarrheic cats using a conventional RT-PCR assay targeting the RNA-dependent RNA polymerase (3D) gene [10]. This seminal study, followed by the complete genome sequencing of the Korean strain FK-13 [9], established the foundational knowledge that FeKoV was a novel picornavirus circulating within feline populations. For several years following this initial report, molecular evidence for FeKoV was geographically restricted to only two countries: South Korea and Italy [3]. This limited geographic footprint suggested either a very recent emergence and spread of the virus or, more plausibly, a lack of targeted surveillance in other regions. The subsequent explosion of studies, particularly from China, has dramatically reshaped this understanding, revealing FeKoV to be a globally distributed agent.

Prevalence in Asia: A Deep Dive into China

China has become the epicenter of FeKoV epidemiological research, providing the most extensive and nuanced data on its prevalence. The first report of FeKoV in China, conducted in the southern region, identified a prevalence of 9.9% (8/81) in diarrhoeic cats, with a statistically significant, albeit weak, correlation coefficient of 0.25 between FeKoV positivity and diarrhea [3]. This study was pivotal as it sequenced the first Chinese field strain, WHJ-1, and demonstrated that FeKoV had undergone rapid mutation since its initial discovery, hinting at a dynamic evolutionary process [3].

Subsequent investigations in Northeast China, encompassing regions such as Shenyang, Changchun, and Harbin, reported a substantially higher overall prevalence of 14.2% (28/197) [8]. This study provided critical insights into the clinical context of infection, revealing a stark disparity in prevalence between symptomatic and asymptomatic cats. Diarrhoeic cats exhibited a prevalence of 19.1% (20/105), while asymptomatic cats showed a significantly lower rate of 8.7% (8/92) [8]. This differential prevalence strongly suggests a pathogenic role for FeKoV, or at least an association with enteric disease, rather than it being a purely commensal member of the gut virome. The study also highlighted the high rate of co-infection, with 20 of the 28 FeKoV-positive samples also testing positive for feline parvovirus (FPV) and/or feline bocavirus (FBoV) [8], a theme that recurs consistently across the literature.

More recent large-scale surveillance in China has employed highly sensitive and specific diagnostic tools, such as multiplex real-time quantitative PCR (RT-qPCR) assays. A study in Guangxi province, Southern China, utilizing a quadruplex RT-qPCR assay on a massive cohort of 1,869 clinical samples, reported a FeKoV positivity rate of 1.93% [1]. This rate is considerably lower than those reported in earlier, smaller studies. This discrepancy is likely multifactorial, reflecting differences in the study population (general clinical samples vs. specifically diarrheic cats), the geographic region, the time period of sampling, and the analytical sensitivity of the diagnostic assay. The quadruplex assay, while highly specific, may have a different detection threshold compared to conventional RT-PCR. Another multiplex qPCR study in China, focusing on feline diarrhea-associated viruses, found a 25.19% (34/135) total co-infection rate among FBoV-1, FeAstV, FeKoV, and FPV, though the specific prevalence of FeKoV alone was not isolated in that analysis [5]. The development and application of these multiplex tools, including another mPCR method capable of detecting FeKoV alongside FCoV, FeAstV, and FPV [14], are revolutionizing the field by enabling high-throughput, simultaneous detection of multiple enteric pathogens, thereby providing a more comprehensive picture of the feline enteric disease complex.

Prevalence in the Middle East and Europe

Outside of Asia, epidemiological data is more sparse but nonetheless revealing. The first detection of FeKoV in the Middle East was reported in Iran, where a prevalence of 4.00% was found in a cohort of 100 fecal samples from both diarrheic and healthy companion cats in Tehran [2]. Notably, all positive samples in this study were from non-diarrheic animals, with the exception of one feline sample that was co-infected with feline panleukopenia virus [2]. This finding contrasts with the Chinese data and underscores the complexity of FeKoV pathogenesis. It suggests that in some populations, FeKoV may circulate primarily as an asymptomatic infection, with clinical disease potentially triggered by host factors, viral strain virulence, or the presence of co-pathogens.

In Europe, data from Italy provides further context. A case-control study investigating the role of feline chaphamaparvovirus (FeChPV) in enteritis also screened for FeKoV, detecting it in 5.3% (2/38) of clinical cases [7]. This places FeKoV as a less prevalent enteric virus compared to FeChPV (36.8%) and FPV (23.7%) in that specific Italian cohort [7]. Further exploration of the feline enteric virome in Italy using both PCR and metagenomic sequencing confirmed the presence of FeKoV in cats with acute gastroenteritis, though it was not the dominant viral species identified [11]. These European studies collectively suggest that while FeKoV is present, its prevalence may be lower than in some Asian populations, and it often exists as part of a complex, multi-pathogen enteric environment.

The Critical Role of Co-infections and Population Dynamics

A recurring and critical theme in the epidemiology of FeKoV is its frequent association with other enteric pathogens. The literature is replete with examples of FeKoV being detected in the context of co-infections. In China, co-infection with FPV and/or FBoV was observed in the majority of FeKoV-positive cats [8]. In Iran, the only symptomatic FeKoV-positive cat was co-infected with panleukopenia [2]. A metagenomic study comparing the enteric virome of cats with feline panleukopenia (FPL) to healthy controls provided powerful evidence for this association. FeKoV infections were significantly more common among FPV-cases (39.1%, 9/23) and were not detected in any of the 36 healthy controls (p < .0001) [13]. This striking finding suggests a strong synergistic or opportunistic relationship between FeKoV and FPV. FPV-induced immunosuppression and damage to the intestinal epithelium may create a permissive environment for FeKoV replication, or conversely, FeKoV infection may exacerbate the severity of FPV-induced disease Mendelian randomization studies would be needed to establish causality, but the epidemiological association is undeniable.

The dynamics of FeKoV shedding, as extrapolated from porcine kobuvirus studies, may also inform feline epidemiology. In swine, kobuvirus shedding is most intense in the post-weaning period, and over 97% of piglets shed the virus at least once in their lifetime [15]. While direct feline data is lacking, it is plausible that young kittens, particularly those in high-density environments like shelters or catteries, represent a key demographic for FeKoV transmission and infection. This aligns with the observation that many studies reporting high FeKoV prevalence are conducted in shelter or multi-cat environments [8, 13]. The interplay between age, immune status, environmental stress, and co-infection with pathogens like FPV likely dictates whether FeKoV infection results in subclinical shedding or overt clinical gastroenteritis.

Methodological Considerations and Global Surveillance Gaps

The wide variation in reported FeKoV prevalence (from ~2% to ~19%) is a direct consequence of significant methodological heterogeneity across studies. Key variables include: (1) Study Population: Studies focusing exclusively on diarrheic cats [3, 10] consistently report higher prevalence than those including asymptomatic or general clinical populations [1, 2]. (2) Diagnostic Assay: The sensitivity and specificity of the detection method are paramount. Conventional RT-PCR, nested PCR, and various qPCR assays have different limits of detection. The LOD for FeKoV in one quadruplex RT-qPCR was 109.761 copies/reaction [1], while singleplex qPCR assays can achieve a LOD of up to 10 copies [5]. (3) Geographic and Temporal Variation: FeKoV, like all RNA viruses, is subject to genetic drift and potentially shift through recombination [4]. The prevalence and dominant strains can vary significantly by region and over time, as evidenced by the phylogenetic clustering of Chinese strains according to their geographical origin [8]. (4) Sample Size and Selection Bias: Many early studies had small sample sizes [3, 10], which can lead to imprecise prevalence estimates. Larger, well-designed cross-sectional studies are needed to establish baseline prevalence rates in different feline populations.

Despite the growing body of evidence, significant global surveillance gaps remain. Data from the Americas, Africa, and Australia are almost entirely absent. The World Organisation for Animal Health (WOAH) does not currently list FeKoV as a notifiable disease, and there are no coordinated global surveillance programs akin to those for rabies or avian influenza. The zoonotic potential of FeKoV, while considered low, remains an open question that warrants further investigation, particularly given the close phylogenetic relationship between feline, canine, and human Aichivirus A strains [2, 10]. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have not issued specific guidelines for FeKoV, reflecting its current status as an emerging pathogen of primarily veterinary concern Mendelian randomization studies are needed to confirm causality. The development and standardization of diagnostic tools, coupled with large-scale, multi-national surveillance efforts, are essential next steps to fully elucidate the global epidemiology of FeKoV and its true impact on feline health.

Molecular Diagnostic Assays for Feline Kobuvirus Detection

The accurate and timely detection of feline kobuvirus (FeKoV) RNA is paramount for understanding its epidemiology, clinical significance, and evolutionary dynamics. Since its initial identification in 2013 in South Korea [9, 10], the development of robust molecular diagnostic tools has progressed rapidly, evolving from conventional endpoint reverse transcription polymerase chain reaction (RT-PCR) to highly multiplexed real-time quantitative platforms. These assays are indispensable not only for routine clinical diagnostics in veterinary practice but also for large-scale epidemiological surveillance, co-infection studies, and genomic characterization of circulating strains. The choice of assay depends on the specific diagnostic objective, whether it requires high-throughput screening, absolute quantification, pan-kobuvirus detection, or simultaneous identification of multiple enteric pathogens.

Conventional and Nested RT-PCR Approaches

The earliest molecular evidence for FeKoV relied on conventional RT-PCR, a foundational technique that remains valuable for resource-limited settings and for generating amplicons for downstream Sanger sequencing. Initial studies, such as those by Chung et al. (2013) in South Korea, utilized primers targeting the RNA-dependent RNA polymerase (3D) gene, a highly conserved region within the Picornaviridae family, facilitating the first detection of FeKoV in diarrheic cats [10]. This approach demonstrated a prevalence of 14.5% (6/39) in the sampled population. Subsequently, Lu et al. (2018) employed a similar strategy using degenerate primers designed against the conserved overlapping region of the FeKoV genome to amplify near-complete genomes from Chinese field strains, notably the WHJ-1 strain [3]. The use of degenerate bases in primer design is a critical strategy for accommodating the genetic variability observed among kobuvirus isolates, particularly as the virus has demonstrated rapid mutation since its discovery [3].

In a comprehensive surveillance study across Northeast China, Niu et al. (2018) employed an RT-PCR assay with universal primers targeting the 3D gene of all kobuviruses, achieving an overall detection rate of 14.2% (28/197) in fecal samples [8]. This approach allowed for the initial screening and subsequent phylogenetic characterization based on partial 3D sequences. The sensitivity of conventional RT-PCR, however, is inherently limited compared to real-time methods. While these assays were instrumental in establishing FeKoV’s presence in South Korea, Italy, and China [3, 10], they typically require post-amplification processing (gel electrophoresis), are not quantitative, and may lack the sensitivity to detect low viral loads often seen in subclinical or carrier animals. For instance, studies in Iran using conventional PCR identified FeKoV in 4% of cats, but only in non-diarrheic animals or those co-infected with other pathogens [2], highlighting the need for more sensitive tools to resolve the virus’s role in disease.

Real-Time Quantitative RT-PCR (RT-qPCR) and Multiplex Developments

The advent of real-time quantitative RT-PCR (RT-qPCR) marked a significant advancement, offering superior sensitivity, specificity, and the ability to quantify viral nucleic acid in real time. This is particularly crucial for FeKoV, as viral load quantification can help differentiate between active infection and incidental shedding.

Quadruplex RT-qPCR for Feline Enteroviruses

A landmark development in FeKoV diagnostics is the quadruplex RT-qPCR assay established by Shi et al. (2024). This assay simultaneously detects and discriminates FeKoV, feline astrovirus (FeAstV), feline bufavirus (FeBuV), and feline rotavirus (FRV) in a single reaction [1]. The assay targets the FeKoV VP1 gene, a region encoding the major capsid protein that is more variable than the 3D gene but crucial for genotyping and understanding antigenic diversity. Following rigorous optimization of reaction conditions, including primer/probe concentrations, annealing temperatures, and cycling parameters, the assay achieved exceptionally high performance metrics. The limits of detection (LOD) for FeKoV was 109.761 copies per reaction, demonstrating high analytical sensitivity [1]. The intra- and inter-assay coefficients of variation (CV) were remarkably low (0.15–1.61% and 0.15–1.59%, respectively), indicating outstanding reproducibility. When applied to 1,869 clinical samples from Guangxi, China, the assay revealed a FeKoV positivity rate of 1.93%, with a 99.63% coincidence rate compared to reference methods [1]. This level of agreement underscores the assay’s clinical reliability and its utility for routine diagnostic panels in veterinary laboratories. The inclusion of an internal positive control in such multiplex designs is vital to rule out PCR inhibition, a common issue in fecal samples [1].

Triplex and Quadruplex Real-Time PCR for Diarrhea-Associated Viruses

Zou et al. (2022) developed another critical multiplex real-time PCR (qPCR) panel targeting FeKoV alongside feline bocavirus 1 (FBoV-1), FeAstV, and feline parvovirus (FPV) [5]. This TaqMan probe-based quadruplex assay achieved a LOD of 100 copies per reaction for the multiplex format, with correlation coefficients exceeding 0.995 across all targets. The single-plex version, which served as a comparator, reached a LOD of up to 10 copies, confirming that the multiplex format, while highly efficient, incurs a slight reduction in sensitivity due to competitive reagent dynamics [5]. The clinical validation of this assay in 135 samples revealed a total co-infection rate of 25.19% (34/135) involving at least two of the four viruses, and a 1.48% (2/135) rate of quadruple infection [5]. This high rate of co-infection is consistent with the emerging view that FeKoV frequently circulates within a complex enteric virome, often alongside FPV, FBoV, FeAstV, and other agents [7, 13]. The detection of such polymicrobial infections is critical, as co-infections can exacerbate clinical disease severity, particularly in kittens and immunosuppressed animals [13].

Conventional Multiplex PCR (mPCR)

While real-time methods offer quantitative advantages, conventional multiplex PCR (mPCR) remains a cost-effective and accessible alternative for laboratories without real-time instrumentation. Xiao et al. (2022) developed two mPCR assays: one for intestinal pathogens (FCoV, FeAstV, FPV, FeKoV) and another for respiratory pathogens. The intestinal mPCR demonstrated a detection limit of 10³ copies/µL for FeKoV, which is sufficient for detecting moderate to high viral loads in clinical samples [14]. The specificity of this mPCR was validated against a panel of other feline pathogens, showing no cross-reactivity. Although less sensitive than qPCR, this assay provides a valuable screening tool for epidemiological studies in regions with limited resources, allowing for simultaneous detection of multiple enteric viruses at a lower cost per test [14].

Detection of Co-Infections and the Role of the Enteric Virome

The clinical significance of FeKoV is inextricably linked to its frequent occurrence as part of a polymicrobial infection. Diagnostic assays that can detect multiple pathogens simultaneously are therefore essential. The quadruplex RT-qPCR by Shi et al. (2024) and the multiplex qPCR by Zou et al. (2022) are paradigm examples of this shift toward syndromic diagnostic panels [1, 5]. These tools have enabled researchers to delineate the complex interactions within the feline enteric virome.

For instance, a meta-transcriptomic and metagenomic study by Van Brussel et al. (2022) revealed that FeKoV infections were significantly more common in cats with feline panleukopenia (FPL) (39.1%, 9/23) compared to healthy controls (0%, 0/36; p <0.0001) [13]. This statistically significant association suggests that FPV infection may predispose cats to FeKoV acquisition or reactivation, or that FeKoV co-infection may contribute to the severity of FPL. Similarly, studies from Italy have detected FeKoV in 5.3% of cats with acute gastroenteritis, often in co-infection with feline chaphamaparvovirus and FPV [7, 11]. The ability to concurrently detect these agents in a single assay, as demonstrated by the aforementioned multiplex platforms, is invaluable for unraveling the mechanistic basis of these co-infections and for guiding appropriate therapeutic interventions, which may need to address viral, bacterial, and parasitic components.

The presence of FeKoV in asymptomatic cats, as noted in various studies [2, 8], further complicates the diagnostic picture. Quantitative assays are particularly useful here, as a high viral load is more likely to be clinically relevant than a low-level or incidental detection. The LOD data provided for the quadruplex RT-qPCR (109.761 copies/reaction) establishes a benchmark for defining a positive result, though veterinary clinicians must integrate this quantitative data with clinical signs and other laboratory findings to determine causality [1].

Advanced and Emerging Technologies

Beyond conventional and real-time PCR, advanced molecular approaches are expanding our understanding of FeKoV. Whole-genome sequencing, enabled by long-fragment PCR and next-generation sequencing (NGS), has been critical for characterizing the genetic diversity and evolution of FeKoV. Lu et al. (2018) designed three primer pairs with degenerate bases to amplify the near-complete genome of the first Chinese FeKoV strain, WHJ-1, revealing rapid mutation rates since the virus’s discovery [3]. Similarly, Niu et al. (2018) obtained two complete polyprotein genomes from Northeast China, demonstrating that FeKoV strains cluster geographically, albeit with limited sequence support [8].

Sequence-independent single-primer amplification (SISPA) coupled with Oxford Nanopore Technologies sequencing has been employed to characterize the feline enteric virome, including FeKoV, in cats with acute gastroenteritis [11]. This unbiased approach can detect unexpected or novel viral strains that would be missed by targeted PCR assays. Such metagenomic approaches are invaluable for ongoing surveillance, particularly as FeKoV continues to evolve and potentially generate recombinant strains. Indeed, a study on canine kobuvirus identified a novel recombinant of canine and feline kobuvirus [4], highlighting the potential for cross-species transmission and genetic exchange that could impact diagnostic target regions.

Finally, the standardization and validation of these assays are critical for their adoption in regulatory and reference settings. Organizations such as the World Organisation for Animal Health (WOAH) provide frameworks for validating diagnostic tests for veterinary use. While specific WOAH guidelines for FeKoV do not yet exist, the principles of analytical specificity, sensitivity, reproducibility, and diagnostic accuracy upheld in these multiplex RT-qPCR studies [1, 5] align with international standards for pathogen detection. The inclusion of the CDC and WHO in discussions of diagnostic assay validation is more relevant for zoonotic kobuviruses (e.g., Aichi virus), but the rigorous methodology applied to these feline assays sets a high bar for future diagnostic development in companion animal virology.

Zoonotic Potential and Public Health Implications

Taxonomic Context and Evolutionary Relationships as a Basis for Zoonotic Concern

Feline kobuvirus (FeKoV), classified within the species Aichivirus A of the genus Kobuvirus in the family Picornaviridae, occupies a phylogenetic position that necessitates rigorous scrutiny from a public health perspective [3, 10]. The genus Kobuvirus includes Aichi virus, a recognized human enteric pathogen first identified in association with oyster-associated gastroenteritis outbreaks in Japan, alongside closely related viruses detected in a broad range of mammalian hosts including cattle, swine, sheep, mice, dogs, and cats [10, 16]. The close genetic relatedness between FeKoV, canine kobuvirus (CaKoV), and human Aichi virus, as repeatedly demonstrated in phylogenetic analyses based on both the 3D polymerase and VP1 capsid protein genes, establishes a fundamental biological plausibility for interspecies transmission events [10, 16]. Indeed, early molecular characterization of FeKoV strains from South Korea demonstrated that feline kobuviruses clustered most closely with canine kobuviruses and human Aichi virus within the kobuvirus phylogenetic tree, forming a monophyletic group that suggests a shared evolutionary ancestry and potentially conserved receptor usage patterns [10]. This taxonomic intimacy is not merely a matter of academic interest; it raises substantive questions regarding the capacity of these viruses to breach species barriers under appropriate ecological or epidemiological pressures.

The evolutionary dynamics of kobuviruses further amplify these concerns. Bayesian evolutionary analysis of CaKoV VP1 sequences has revealed an estimated evolutionary rate of 1.36 × 10⁻⁴ substitutions per site per year, with divergence time estimates suggesting that canine and feline kobuviruses shared a common ancestor approximately 19.44 years ago [4]. This relatively rapid evolutionary rate, characteristic of RNA viruses with high mutation frequencies, provides the genetic plasticity necessary for host range expansion. Critically, a novel CaKoV strain identified in Shanghai, China, was characterized as a recombinant of canine and feline kobuvirus, providing direct molecular evidence for inter-species genetic exchange between these two closely related but distinct viral lineages [4]. Such recombination events can facilitate the emergence of viral variants with altered host tropism, tissue specificity, or virulence profiles, and represent a well-documented mechanism by which picornaviruses adapt to new hosts. The detection of a naturally occurring recombinant between feline and canine kobuvirus underscores the fluidity of genetic boundaries within the Aichivirus A species and serves as a sentinel indicator of ongoing evolutionary processes that could potentially generate variants with zoonotic capacity.

Epidemiological Evidence for Cross-Species Transmission Dynamics

While direct evidence of FeKoV transmission to humans remains absent in the current literature, the epidemiological patterns observed in feline populations and the known behavior of related kobuviruses in other species demand careful consideration. The detection of FeKoV in both diarrheic and asymptomatic cats across geographically disparate regions, including South Korea [9, 10], China [3, 8], Italy [7, 11], Iran [2], and Vietnam [12], establishes that the virus circulates widely in domestic feline populations, often at substantial prevalence rates. In northeast China, FeKoV was identified in 14.2% (28/197) of fecal samples, with a significantly higher prevalence in diarrheic cats (19.1%) compared to asymptomatic individuals (8.7%) [8]. Similarly, a study from southern China reported a prevalence of 9.9% (8/81) in diarrheic cats [3]. These prevalence figures indicate that cats represent a substantial viral reservoir, with infected animals shedding potentially infectious viral particles into the environment through feces.

The persistence of FeKoV in cat populations is further complicated by the high frequency of co-infections with other enteric pathogens. In cats with feline panleukopenia (FPL), FeKoV was detected in 39.1% (9/23) of cases, while it was entirely absent in age-matched healthy control cats, a statistically significant association (p < 0.0001) [13]. This finding suggests that FeKoV may act as an opportunistic pathogen, exploiting the immunosuppression induced by parvovirus infection to achieve enhanced replication and shedding. Co-infections with feline parvovirus (FPV) have been repeatedly documented, with one study reporting that 20 of 28 FeKoV-positive samples were co-infected with FPV and/or feline bocavirus [8]. In dogs, CaKoV has been detected in 25% of stray dogs, with co-infection rates of 26.67% for canine distemper virus and 73.33% for canine astrovirus [4], while in Brazil, all three CaKoV-positive diarrheic dogs were co-infected with canine parvovirus subtype 2b [16]. These high co-infection rates have significant public health implications: co-infected animals may shed higher viral loads, experience prolonged shedding duration, and present with more severe clinical signs that increase the likelihood of human contact with contaminated materials.

The potential for fomite-mediated and environmental transmission routes must also be considered. Kobuviruses, as non-enveloped picornaviruses, are inherently resistant to environmental degradation and many common disinfectants, a characteristic that facilitates their persistence in the environment. In swine production systems, porcine kobuvirus shedding dynamics indicate that environmental contamination plays a significant role in transmission, with >97% of piglets shedding kobuvirus at least once in their lifetime [15]. While analogous studies have not been performed for FeKoV, the physicochemical properties shared among kobuviruses suggest that feline strains likely exhibit similar environmental stability. The detection of FeKoV in shelters, multi-cat households, and veterinary clinics [7, 11] indicates that these environments could serve as points of sustained viral circulation and potential spillover to humans, particularly veterinary personnel, shelter workers, and immunocompromised owners who have close, prolonged contact with infected cats.

Indirect Public Health Implications and Diagnostic Surveillance Needs

Beyond the direct question of zoonotic transmission, FeKoV has implications for public health through its role as a contributor to feline gastroenteritis and its interactions with the broader enteric virome. The World Health Organization (WHO) recognizes zoonotic enteric pathogens as a significant cause of human disease, particularly in children, the elderly, and immunocompromised individuals. The fact that FeKoV is frequently detected in cats with acute gastroenteritis, and that these cats may present to veterinary clinics with clinical signs (vomiting, diarrhea, dehydration) that are indistinguishable from those caused by recognized zoonotic agents such as Campylobacter, Salmonella, or norovirus, complicates differential diagnosis and infection control practices [1, 5, 11]. Veterinary personnel and cat owners may inadvertently attribute clinical signs to FeKoV without considering other zoonotic pathogens that could be present as co-infections or alternative etiologies.

The development of advanced molecular diagnostic tools, including quadruplex RT-qPCR assays capable of simultaneously detecting FeKoV alongside feline astrovirus, bufavirus, and rotavirus [1], as well as multiplex PCR panels that include FeKoV with feline coronavirus, parvovirus, and other enteric pathogens [5, 14], represents a significant advancement for both veterinary and public health surveillance. These tools enable rapid, sensitive, and specific identification of FeKoV in clinical samples, facilitating epidemiological monitoring and outbreak investigations. However, the routine inclusion of FeKoV in diagnostic panels for cats with gastroenteritis also raises the question of whether similar surveillance should be extended to human populations, particularly those with occupational exposure to cats. The World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) have emphasized the importance of a One Health approach to emerging infectious diseases, recognizing that surveillance in animal populations can provide early warning signals for potential zoonotic threats. Given that CaKoV has been detected in diarrheic dogs in Brazil [16], Iran [2], China [4, 6], and multiple other countries, and that FeKoV is now recognized as a globally distributed feline pathogen, a coordinated surveillance framework that includes kobuvirus monitoring in both companion animal and human populations is warranted.

The public health significance of FeKoV must also be considered in the context of the human-animal bond and the increasing proximity between humans and their companion animals. Cats are among the most popular pets worldwide, with tens of millions of households sharing close living spaces with feline companions. The 2021 AAHA/AAFP Feline Life Stage Guidelines emphasize the importance of addressing zoonoses and human safety as part of routine feline healthcare [17], underscoring the veterinary profession’s recognition of this interface. Immunocompromised individuals, including those undergoing chemotherapy, organ transplant recipients, HIV/AIDS patients, and the elderly, represent a particularly vulnerable population for whom even low-risk zoonotic agents can pose substantial health threats. While FeKoV has not been demonstrated to cause human disease, the precautionary principle and the precedent set by other emerging picornaviruses (e.g., hepatitis E virus, which originated in swine and now causes significant human morbidity) mandate ongoing vigilance. The detection of FeKoV in fecal samples from both diarrheic and healthy cats [8, 11] indicates that even clinically normal cats can shed the virus, creating a continuous low-level exposure risk for owners who handle litter boxes, clean contaminated surfaces, or engage in close grooming behaviors with their pets.

Risk Assessment and Recommendations for Public Health Practice

Current evidence does not support the classification of FeKoV as a confirmed zoonotic pathogen. No cases of human illness attributable to FeKoV have been reported in the peer-reviewed literature, and experimental studies assessing the capacity of FeKoV to infect human cell lines or human intestinal organoids have not been conducted. However, the absence of evidence is not evidence of absence, and the biological, epidemiological, and evolutionary considerations outlined above provide compelling justification for a precautionary approach. The United States Centers for Disease Control and Prevention (CDC) and the WHO have consistently emphasized that the emergence of novel zoonotic diseases is most often preceded by a period of unrecognized or underestimated risk, during which viral circulation in animal reservoirs goes undetected or unmonitored.

From a public health perspective, the following measures are prudent. First, veterinary diagnostic laboratories should consider including FeKoV in routine enteric pathogen panels for cats, at least until its clinical significance and zoonotic potential are more fully characterized. The availability of validated multiplex assays [1, 5, 14] makes this increasingly feasible and cost-effective. Second, infection control practices in veterinary settings should assume that any cat presenting with acute gastroenteritis could be shedding a potential zoonotic agent, including FeKoV, and appropriate barrier precautions (gloves, hand hygiene, environmental disinfection) should be employed. Third, cat owners, particularly those who are immunocompromised, should be counseled on basic hygiene measures when handling feline waste, including the use of gloves for litter box cleaning, prompt disposal of feces, and thorough hand washing. Fourth, public health agencies should consider including kobuviruses in their emerging infectious disease surveillance portfolios, recognizing that the companion animal-human interface represents an underexplored frontier for zoonotic disease emergence. Finally, targeted research initiatives are urgently needed to assess the capacity of FeKoV to replicate in human cells, to determine its seroprevalence in human populations with occupational or domestic feline exposure, and to evaluate the effectiveness of disinfectants and hygiene protocols in reducing environmental viral load.

In conclusion, while FeKoV does not currently meet the criteria for a recognized zoonotic pathogen, its taxonomic position within a genus that includes a human pathogen, its demonstrated capacity for genetic recombination and rapid evolution, its high prevalence in domestic cat populations worldwide, and the close physical proximity between cats and humans collectively establish a credible basis for zoonotic concern. The veterinary and public health communities must maintain a state of informed vigilance, supported by robust surveillance systems and evidence-based infection control practices, to ensure that any potential zoonotic emergence is detected at the earliest possible opportunity.

References

[1] Shi K, He M, Long F, He J, Yin Y, Feng S, et al.. Development of a Quadruplex RT-qPCR for the Detection of Feline Kobuvirus, Feline Astrovirus, Feline Bufavirus, and Feline Rotavirus. Microbiology Research. 2024. DOI: https://doi.org/10.3390/microbiolres15040143

[2] Aftab G, Arfaee F, Akhtardanesh B, Brojeni GN. Molecular characterization of canine and feline kobuvirus infections in Iran. Veterinary Research Forum. 2022. DOI: https://doi.org/10.30466/vrf.2020.128667.2975

[3] Lu G, Zhang X, Luo J, Sun Y, Xu H, Huang J, et al.. First report and genetic characterization of feline kobuvirus in diarrhoeic cats in China. Transboundary and Emerging Diseases. 2018. DOI: https://doi.org/10.1111/tbed.12916

[4] Deng B, Song Y, Li L, Zhou Y, Zhu C, Zhang W, et al.. Detection and genetic characterization of canine kobuvirus from stray dogs in Shanghai, China. Archives of Virology. 2023. DOI: https://doi.org/10.1007/s00705-023-05710-z

[5] Zou J, Yu J, Mu Y, Xie X, Wang R, Wu H, et al.. Development of a TaqMan-based multiplex real-time PCR for simultaneous detection of four feline diarrhea-associated viruses. Frontiers in Veterinary Science. 2022. DOI: https://doi.org/10.3389/fvets.2022.1005759

[6] Wang Y, Cui Y, Li Y, Wang X, Yang K, Zhang D, et al.. Identification and full-genome sequencing of canine kobuvirus in canine fecal samples collected from Anhui Province, eastern China. Archives of Virology. 2020. DOI: https://doi.org/10.1007/s00705-020-04773-6

[7] Profio FD, Sarchese V, Palombieri A, Fruci P, Massirio I, Martella V, et al.. Feline chaphamaparvovirus (FeChPV) in cats with enteritis and upper respiratory tract disease (URTD).. Transboundary and Emerging Diseases. 2021. DOI: https://doi.org/10.1111/tbed.14032

[8] Niu T, Yi S, Wang X, Wang L, Guo B, Zhao L, et al.. Detection and genetic characterization of kobuvirus in cats: The first molecular evidence from Northeast China. Infection, Genetics and Evolution. 2018. DOI: https://doi.org/10.1016/j.meegid.2018.12.010

[9] Cho Y, Lim S, Kim YK, Song J, Lee J, An D. Molecular Characterization of the Full Kobuvirus Genome in a Cat. Genome Announcements. 2014. DOI: https://doi.org/10.1128/genomeA.00420-14

[10] Chung J, Kim S, Kim Y, Lee M, Lee K, Oem J. Detection and genetic characterization of feline kobuviruses. Virus genes. 2013. DOI: https://doi.org/10.1007/s11262-013-0953-8

[11] Profio FD, Sarchese V, Fruci P, Aste G, Martella V, Palombieri A, et al.. Exploring the Enteric Virome of Cats with Acute Gastroenteritis. Veterinary Sciences. 2023. DOI: https://doi.org/10.3390/vetsci10050362

[12] Dong HV, Tran G, Nguyen YHT, Ngo TC, Rattanasrisomporn A, Boonkaewwan C, et al.. Co-circulation and genetic characterization of genotype I and II feline bocavirus strains in domestic cats from Northern Vietnam. Veterinary World. 2025. DOI: https://doi.org/10.14202/vetworld.2025.1590-1598

[13] Brussel KV, Wang X, Shi M, Carrai M, Feng S, Li J, et al.. The enteric virome of cats with feline panleukopenia differs in abundance and diversity from healthy cats. Transboundary and Emerging Diseases. 2022. DOI: https://doi.org/10.1111/tbed.14646

[14] Xiao X, Hao X, Chen B, Zhou P, Li S. Two Multiplex PCR Methods for Detecting Several Pathogens Associated with Feline Respiratory and Intestinal Tracts. Veterinary Sciences. 2022. DOI: https://doi.org/10.3390/vetsci10010014

[15] Nantel-Fortier N, Lachapelle V, Letellier A, L’Homme Y, Brassard J. Kobuvirus shedding dynamics in a swine production system and their association with diarrhea.. Veterinary Microbiology. 2019. DOI: https://doi.org/10.1016/j.vetmic.2019.07.023

[16] Miyabe F, Ribeiro J, Alfieri A, Alfieri A. Detection of canine kobuvirus RNA in diarrheic fecal samples of dogs with parvoviruses. Brazilian Journal of Microbiology. 2019. DOI: https://doi.org/10.1007/s42770-019-00095-1

[17] Quimby J, Gowland S, Carney H, DePorter T, Plummer P, Westropp J. 2021 AAHA/AAFP Feline Life Stage Guidelines. Journal of feline medicine and surgery. 2021. DOI: https://doi.org/10.1177/1098612X21993657